Tarsons Products Limited IPO (Tarsons Products IPO) Details,GMP, Subscription and Issue Price
Details of the Tarsons Products Limited IPO - Tarsons IPO:
- Issue Amount: ₹1,024 Cr
- Face Value : ₹2 per share
- Price Band : ₹635 to ₹662
- Lot Size : 22 shares
Important dates for Tarsons Products Limited IPO - Tarsons IPO:
- IPO Open: Monday, November 15, 2021
- IPO Close: Wednesday, November 17, 2021
- Finalization of basis of allotment: 23rd November 2021
- Refunds/Unblocking ASBA fund: 24th November 2021
- Credit of equity shares to DP account: 25th November 2021
- Trading commences: 26th November 2021
Grey Market Premium of Tarsons Products Limited IPO:
In the following data we can see how the Grey Market Premium of Tarsons Products Limited varied in last few days
- 16th Nov - Rs. 200 (30.2% to Issue Price of Rs. 662)
- 16th Nov - Rs. 200 (30.2% to Issue Price of Rs. 662)
- 15th Nov - Rs. 220 (33.2% to Issue Price of Rs. 662)
- 13th Nov - Rs. 150
- 12th Nov - Rs. 150
- 11th Nov - Rs. 150
- 10th Nov - Rs. 150
Tarsons Products Limited IPO Subscription on 17th November 2021:
Tarsons Products Limited IPO is subscribed 77.47 times on 17th November 2021 16:40 am
- Qualified Institutional Buyers (QIB) - 115.77 times Subscribed
- Retail Individual Investors (RII) - 10.52 times Subscribed
- Non Institutional investors (NII) - 184.58 times Subscribed
- Employees - 1.83 times Subscribed
Company background:
The company is an Indian labware company engaged in the designing, development,
manufacturing and marketing of ‘consumables’, ‘reusables’ and ‘others’ including
benchtop equipment, used in various laboratories across research organizations,
academia institutes, pharmaceutical companies, Contract Research Organizations
(“CROs”), Diagnostic companies and hospitals. The company manufactures a range of
quality labware products which helps advance scientific discovery and improve
healthcare (Source: Frost & Sullivan Report). As of June 30, 2021 it has a diversified
product portfolio with over 1,700 SKUs across 300 products. The company caters to a
diverse range of end customers across various sectors which include research
organizations, academic institutions, pharmaceutical companies, CROs, diagnostic
companies, and hospitals. Some of our end customers include customers such as
Indian Institute of Chemical Technology, National Centre for Biological Sciences
across academic institutes and research organizations; Dr Reddy's Laboratories,
Enzene Biosciences across pharmaceutical sectors; Syngene International, Veeda
Clinical Research across CROs; and Molbio Diagnostics, Agappe Diagnostic,
Metropolis Healthcare, Dr. Lal Path Labs, Mylab Life Solutions across other sectors
such as diagnostics. It distributes products to these end customers on a pan-India
basis through its authorised distributors.
It is one of the leading Indian companies in terms of revenue in the plastic labware
market in India which is estimated as ₹1,225 Cr as of 2020 in value terms and
estimated to expand at a CAGR of 16.00% to reach approximately ₹2,575.5 Cr by year
2025. The company caters to the global plastic laboratory products market which was
estimated to be USD 8.4 billion in 2020 and is expected to expand at a CAGR of
approximately 10.50% to reach approximately USD 13.8 billion by year 2025 (Source:
Frost & Sullivan Report). It supplies its products to over 40 countries across both
developed and emerging markets through a blend of branded and ODMs.
Strengths Of the Tarsons Products Limited IPO:
Risks Associated with Tarsons Products Limited IPO:
Financial Details of Tarsons Products Limited IPO:
Purpose of Tarsons Products Limited IPO:
- Repayment/prepayment of all or certain of the company’s borrowings
- Funding a part of the capital expenditure for the new manufacturing facility at Panchla, West Bengal (the “Proposed Expansion”)
- General corporate purposes
Nice Article
ReplyDelete